HomeCompareCINSF vs EQR

CINSF vs EQR: Dividend Comparison 2026

CINSF yields 2.97% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CINSF wins by $5.87M in total portfolio value· pulled ahead in Year 2
10 years
CINSF
CINSF
● Live price
2.97%
Share price
$1.50
Annual div
$0.04
5Y div CAGR
75.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,766,627.96
Full CINSF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — CINSF vs EQR

📍 CINSF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCINSFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CINSF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CINSF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CINSF
Annual income on $10K today (after 15% tax)
$252.60/yr
After 10yr DRIP, annual income (after tax)
$4,051,633.77/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, CINSF beats the other by $4,048,387.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CINSF + EQR for your $10,000?

CINSF: 50%EQR: 50%
100% EQR50/50100% CINSF
Portfolio after 10yr
$2.98M
Annual income
$2,385,223.78/yr
Blended yield
80.15%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CINSF
No analyst data
Altman Z
0.4
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CINSF buys
0
EQR buys
0
No recent congressional trades found for CINSF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCINSFEQR
Forward yield2.97%4.73%
Annual dividend / share$0.04$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR75.4%15.8%
Portfolio after 10y$5.91M$40.5K
Annual income after 10y$4,766,627.96$3,819.61
Total dividends collected$5.79M$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CINSF vs EQR ($10,000, DRIP)

YearCINSF PortfolioCINSF Income/yrEQR PortfolioEQR Income/yrGap
1$11,221$521.24$11,248$547.57$27.00EQR
2← crossover$12,966$958.80$12,701$666.53+$265.00CINSF
3$15,689$1,816.02$14,405$814.59+$1.3KCINSF
4$20,390$3,602.27$16,413$999.84+$4.0KCINSF
5$29,491$7,674.18$18,795$1,232.92+$10.7KCINSF
6$49,751$18,195.31$21,639$1,527.95+$28.1KCINSF
7$103,550$50,316.94$25,057$1,903.80+$78.5KCINSF
8$282,476$171,676.71$29,197$2,385.87+$253.3KCINSF
9$1,069,940$767,691.47$34,250$3,008.70+$1.04MCINSF
10$5,911,464$4,766,627.96$40,467$3,819.61+$5.87MCINSF

CINSF vs EQR: Complete Analysis 2026

CINSFStock

China Taiping Insurance Holdings Company Limited, an investment holding company, underwrites various insurance and reinsurance products in the People's Republic of China and internationally. The company operates through three business segments: Life Insurance, Property and Casualty Insurance, and Reinsurance. The Life Insurance segment provides life insurance products, such as individual and group life insurance, health insurance, and accident insurance products and annuities. The Property and Casualty Insurance segment offers compulsory motor insurance, liability insurance, credit insurance, guarantee insurance, and short-term accident and health insurance, as well as the related reinsurance products. The Reinsurance segment provides property damage, life, marine cargo and hull, and miscellaneous non-marine reinsurance products. The company also engages in the assets management, insurance intermediary, financial leasing, property investment, and securities dealing and broking, as well as in elderly care investment businesses; and manages investment funds. In addition, it provides corporate and personal retirement insurance products; and back-to-back financing arrangement, as well as insurance broking and agency services. The company was formerly known as China Insurance International Holdings Company Limited and changed its name to China Taiping Insurance Holdings Company Limited in August 2009. The company was incorporated in 2000 and is headquartered in North Point, Hong Kong. China Taiping Insurance Holdings Company Limited is a subsidiary of China Taiping Insurance Group (HK) Company Limited.

Full CINSF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CINSF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CINSF vs SCHDCINSF vs JEPICINSF vs OCINSF vs KOCINSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.